February 15, 2021
Otsuka Holdings netted 3.3% growth in its pharma revenue in 2020 thanks to brisk performances seen with four global brands including the antipsychotic agents Abilify Maintena (aripiprazole) and tolvaptan, a selective vasopressin V 2 receptor antagonist also called Samsca and...read more